GSI Seminar Series
A semimonthly series held on the first and third Tuesdays from 3:00-4:00pm in X 714-715 (unless otherwise noted). The dual goals of this seminar series are to invite extramural speakers who are internationally recognized researchers at the vanguard of genetics and genomics research, and to sponsor intramural speakers in an effort to build interactions and collaborations among Boston University investigators engaged in genetics and genomics research.
To help increase the accessibility of the GSI Seminar Series, they will be broadcast online. For more information please visit the Webinar Page.
If you would like to join the GSI Seminar Committee, have suggestions for invited speakers, or if you would like to present an intramural seminar, please email firstname.lastname@example.org.
For a list of past seminars, please visit the Past Seminars page.
To get more information, click on speakers name to link to their website.
Fall 2013 and Spring 2014
Targeted Next-Generation Sequencing Approaches for Rare Varient Discovery
Scott Leppanen, Ph.D.
Field Application Scientist
Agilent Technologies, Inc.
Mechanisms of genetic risk in chronic pancreatitis
Professor, Department of Molecular and Cell Biology,
Henry M. Goldman School of Dental Medicine
(11:30AM– 12:30 PM in Keefer Auditorium)
lncRNAs: Function and Mechanism in Controlling Cellular Identity
Assistant Professor, Division of Biology and Biological Engineering
California Institute of Technology.
Topic: Predicting the functional impact of genetic variants obtained from high-throughput sequencing data
Group Leader, Analytic and Translational Genetics Unit, MGH
Assistant Professor, Harvard Medical School
Research Affiliate, Broad Institute of Harvard and MIT
3-4pm in Keefer Auditorium, E111
Reception following in the Wilkins Board Room E120
Building a Biotech Company from the Ground Up: The Story of Regeneron
President, Regeneron Laboratories
Chief Scientific Officer, Regeneron Pharmaceuticals, Inc.
Member, National Academy of Sciences
Fishing for Effective Therapeutics for T-Lymphoblastic Leukemia
Department of Pharmacology & Experimental Therapeutics
Department of Medicine, Section of Hematology and Medical Oncology
Cancer Research Center
Boston University School of Medicine
(3-4 pm in Keefer Auditorium, E111)
Genome Engineering Using CRISPR-Cas9
Assistant Professor, Department of Brain and Cognitive Sciences
McGovern Institute, MIT and Broad Institute of MIT and Harvard
Topic: Translating dosage compensation to trisomy 21
Professor of Cell and Developmental Biology & Pediatrics
University of Massachusetts Medical School
Evolution and function of mammalian exons
(Note: to be held in L112)
Professor of Biology and Biological Engineering
Director, Computational and Systems Biology Ph.D. Program
Massachusetts Institute of Technology
Topic: Identification of cis regulatory elements and gene regulatory networks
Associate Professor of Medicine and Pathology
Brigham & Women’s Hospital and Harvard Medical School